Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2025-01-27 00:00:00 ET · period of report 2025-01-23 · accession 0001628280-25-002716 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-27 | 2025-01-23 | ARWR | OLUKOTUN ADEOYE Y | Dir | S - Sale | $21.00 | -959 | 35.8K | -3% | -$20.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-23 | S | D | 959 | $21.00 | 35,781 | D | — | — | (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |